Search results
Results From The WOW.Com Content Network
Do No Harm is a United States medical and policy advocacy group. The group opposes gender-affirming care for minors and diversity, equity and inclusion efforts in medicine and medical education, including race-conscious medical school admissions and other identity-based considerations regarding health care decision-making. [ 1 ]
First, do no harm, or in Latin primum non nocere, a medical injunction; Do No Harm: Stories of Life, Death and Brain Surgery, a 2014 book by Henry Marsh; Harm principle, a philosophical concept "Do No Harm" (HR report on Bahrain), a 2011 report by Physicians for Human Rights; Do No Harm (organization), a United States anti-trans advocacy group
Pages in category "Organizations that oppose transgender rights in the United States" The following 12 pages are in this category, out of 12 total. This list may not reflect recent changes .
A spokesperson for the NLPC told Fortune that the organization believes companies should avoid polarizing political positions, explaining: “We believe corporate public companies need to be ...
The following are a list of organizations which oppose transgender rights. Some of these groups may oppose all LGBTQ rights, while others may be supportive of lesbian, gay, and bisexual rights, but oppose transgender rights. This category includes "gender-critical" or trans-exclusionary radical feminist groups.
For premium support please call: 800-290-4726 more ways to reach us
She is involved in numerous organizations working at the intersection of social justice and health, including the Do No Harm Coalition [6] and Deep Medicine Circle. [7] She was recognized in 2021 with the Women Leaders in Medicine Award by the American Medical Student Association.
Beneficence: the philosophy of "Do no harm" while maximizing benefits for the research project and minimizing risks to the research subjects; and Justice : ensuring reasonable, non-exploitative, and well-considered procedures are administered fairly — the fair distribution of costs and benefits to potential research participants — and equally.